Grading of invasive breast carcinoma: the way forward

C Van Dooijeweert, PJ Van Diest, IO Ellis - Virchows Archiv, 2022 - Springer
Histologic grading has been a simple and inexpensive method to assess tumor behavior
and prognosis of invasive breast cancer grading, thereby identifying patients at risk for …

A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer

M Amgad, JM Hodge, MAT Elsebaie, C Bodelon… - Nature Medicine, 2024 - nature.com
Breast cancer is a heterogeneous disease with variable survival outcomes. Pathologists
grade the microscopic appearance of breast tissue using the Nottingham criteria, which are …

Survival disparities in US Black compared to White women with hormone receptor positive-HER2 negative breast cancer

LA Lovejoy, CD Shriver, S Haricharan… - International journal of …, 2023 - mdpi.com
Black women in the US have significantly higher breast cancer mortality than White women.
Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women …

Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study

KE Reeder‐Hayes, SE Mayer, AF Olshan… - Cancer, 2019 - Wiley Online Library
Background After controlling for baseline disease factors, researchers have found that black
women have worse breast cancer survival, and this suggests that treatment differences may …

[HTML][HTML] The era of multigene panels comes? The clinical utility of oncotype DX and MammaPrint

L Xin, YH Liu, TA Martin, WG Jiang - World journal of oncology, 2017 - ncbi.nlm.nih.gov
Abstract The AJCC Cancer Staging Manual, eighth edition published in late 2016, will
become the new global guideline for cancer diagnosis and treatment from January 1, 2018 …

Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017

P Fwelo, ZI Yusuf, A Adjei, G Huynh, XL Du - Breast Cancer Research and …, 2022 - Springer
Purpose Although surgical resection is the main modality of treatment for breast cancer,
some patients elect to refuse the recommended surgery. We assessed racial and ethnic …

[HTML][HTML] Breast cancer incidence and risk reduction in the Hispanic population

EJ Power, ML Chin, MM Haq - Cureus, 2018 - ncbi.nlm.nih.gov
Breast cancer is the most common non-skin cancer amongst women worldwide and is the
fifth leading cause of cancer-related mortality overall. It is also the foremost reason for …

From race to racism and disparities to equity: an actionable biopsychosocial approach to breast cancer outcomes

K Reeder-Hayes, ML Roberson, SB Wheeler… - The Cancer …, 2023 - journals.lww.com
Purpose Racial disparities in outcomes of breast cancer in the United States have widened
over more than 3 decades, driven by complex biologic and social factors. In this review, we …

The complex landscape of luminal breast cancer

C Lutz, HA Messal, D Vareslija… - Endocrine-Related …, 2025 - erc.bioscientifica.com
The breast epithelium, vital for mammary gland function, is influenced by oestrogen through
the oestrogen receptor (ER) signalling pathway. Luminal breast cancer (BC), characterised …

Validation of the RSClin risk calculator in the National Cancer Data Base

AGL Vannier, A Dhungana, F Zhao, N Chen… - Cancer, 2024 - Wiley Online Library
Background Guidelines recommend the use of genomic assays such as OncotypeDx to aid
in decisions regarding the use of chemotherapy for hormone receptor–positive, HER2 …